Daily non-political popular news in brief.
Jefferson researchers find nanoparticle shows promise in reducing radiation side effects
11-08-2006 · EurekAlert!With the help of tiny, transparent zebrafish embryos, researchers are hoping to prove that a microscopic nanoparticle can be part of a "new class of radioprotective agents" that help protect normal tissue from radiation damage just as well as standard drugs. They've shown that the nanoparticle, DF-1 -- a soccer ball-shaped, hollow, carbon-based structure known as a fullerene -- is as good as two antioxidant drugs and FDA-approved Amifostine in fending off radiation damage from normal tissue.
Read more »
Keywords: jefferson, researchers, nanoparticle, shows, promise, reducing, radiation, side, effects, researcher, show, effect
« Previous | Next »
Similar news on "Jefferson researchers find nanoparticle shows promise in reducing radiation side effects":
- Study: Re-engineered Gleevec reduces heart risks
12-03-2007 · EurekAlert!
Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib -- best known by its brand name Gleevec -- to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect. The re-design strategy employed in the study is broadly applicable to reducing side effects in other drugs.
Similar news · Read more »
- Researchers propose reason for severe side-effects of Northwick Park clinical trial
01-25-2007 · EurekAlert!
A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris. The research shows that stimulating the molecule CD28 on cells that mediate the immune response, known as T cells, can have an adverse effect if these immune cells have been activated and altered by infection or illness in the past.
Similar news · Read more »
- Weight-loss supplement shows good and bad traits
01-30-2007 · EurekAlert!
A supplement some people turn to in hopes of losing a few pounds may have some previously unknown, unsavory side effects, suggest two new studies. Researchers studied how mice and rats responded to the supplement conjugated linoleic acid (CLA), an essential amino acid found in trace amounts primarily in beef, lamb and milk. Synthetic forms of CLA are marketed as supplements that help reduce body fat, and some manufacturers also tout CLA for reducing the risk of diabetes and certain types of cancer.
Similar news · Read more »
- New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
06-28-2007 · EurekAlert!
A just published scientific study conducted by researchers at the University of Miami School of Nursing in conjunction with The Sirkin Creative Living Center (SCLC) has found that Rescue Remedy, an all-natural remedy created from flower essences, is an effective over-the-counter stress reliever with a comparable effect to traditional pharmaceutical drugs yet without any of the known adverse side effects, including addiction.
Similar news · Read more »
- Ski area affects mountain watershed, UVM study shows
05-17-2007 · EurekAlert!
In the first-ever study to document the effects of ski resort development on water flows and quality in the northeastern US, University of Vermont researchers studied side-by-side watersheds on Mount Mansfield. Their results show greater-than-expected water volume from the developed watershed, suggesting that models derived from timber extraction studies may underestimate the hydrologic effects of resort development. This study provides baseline data that may contribute to new stormwater management approaches in mountainside development.
Similar news · Read more »
- Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
09-10-2007 · EurekAlert!
Researchers have found surprising evidence that an antidepressant (citalopram) may perform as well as a commonly prescribed antipsychotic (risperidone) in the alleviation of severe agitation and psychotic symptoms of dementia. Researchers also found that the antidepressant was associated with "significantly lower" adverse side effects.
Similar news · Read more »
- For treating advanced Parkinson's, new research points to serotonin
02-04-2008 · EurekAlert!
Studies in a mouse model of Parkinson's disease show that side effects caused by repeated use of the drug L-DOPA can be minimized by blocking the serotonin 1B receptor. The finding, reported by researchers at Rockefeller University and the Karolinska Institute, suggests that targeting the 1B receptor may provide an alternative approach for treating advanced Parkinson's disease.
Similar news · Read more »
- Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
- Choline shows promise in reducing behavioral effects associated with prenatal alcohol exposure
02-28-2007 · EurekAlert!
Giving choline to infants who were exposed in the womb to alcohol may mitigate some of the resulting problems. Prenatal alcohol exposure affects physical and central nervous system development, putting children at risk for fetal alcohol spectrum disorders that at their worst include full-blown fetal alcohol syndrome. These disorders can mean a lifetime of potentially serious problems with learning, attention, motor skills and social behavior.
Similar news · Read more »
- Blueberries contain chemical that may help prevent colon cancer
03-25-2007 · EurekAlert!
A compound in blueberries shows promise of preventing colon cancer in animals, according to a joint study by scientists at Rutgers University and the US Department of Agriculture. The compound, pterostilbene, is a potent antioxidant that could be developed into a pill with the potential for fewer side effects than some commercial drugs that are currently used to prevent the disease. The study will be presented in March during the American Chemical Society national meeting.
Similar news · Read more »